NCT07673263Not yet recruiting
Effects of X Box Kinect 360 in Alzheimer's Disease
Effect of 3D Kinect Games With Google Cardboard on Motor Control, Cognition, and Quality of Life in Mild to Moderate Alzheimer's Patient
Source: ClinicalTrials.gov · Last updated 29 Jun 2026
Brief summary (registry, in English)
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, and this number is expected to rise to 78 million by 2023 and 139 million by 2050 (WHO, 2021).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- First submitted
- 23 Jun 2026
- Start date
- 24 Jun 2026
- Primary completion date
- 15 Jul 2026
- Lead sponsor
- Ziauddin University
- Diseases
- Alzheimer disease
- NCT number
- NCT07673263
What you commit to
- Study type: Interventional
- Planned participants: 38
- From 24 Jun 2026 to the primary completion date, 15 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Mental or neurological conditions like schizophrenia, Parkinson's, or stroke.
Other
- Undiagnosed AD patients.
Who the study is looking for
- Alzheimer's disease of age between 50-85 years.
- Diagnosed AD stage Mild to Moderate.
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziauddin University Coordinator of this site? Confirm its status | Karachi | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.